Despite a substantial economic burden of type 2 diabetes (T2D) on the working population, the costs of T2D for employers are not well characterized. We estimated productivity losses and medical costs due to T2D among employees aged 18-64 years using 2018-20MarketScan® databases. We estimated missed days due to absences, short-term disability (STD) , and long-term disability (LTD) attributable to T2D, overall and by age and sex. We converted these losses into costs by multiplying them by an average hourly wage. We used two-part and generalized linear models (controlling for age, sex, state of residence, employer industry type, and Charlson Comorbidity Index score) to estimate the productivity costs and medical costs in total and by service type. All costs were in 20USD. Overall, employees with T2D had 68% higher costs measured in productivity losses and medical services than those without diabetes (Table) , yielding a total cost attributable to T2D of $6,933. Most of the extra cost (90%) was from medical costs, followed by productivity costs due to STD (7%) , absences (2%) , and LTD (1%) . The youngest group had higher STD days and outpatient costs. Females had more absences and STD days and higher outpatient costs than males. Our estimates may assist employers in assessing potential financial gains from improved efforts to prevent and manage T2D in the workplace.


J.Park: None. E.Luman: None. P.Zhang: None.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at